UniProt ID | RAB5A_HUMAN | |
---|---|---|
UniProt AC | P20339 | |
Protein Name | Ras-related protein Rab-5A | |
Gene Name | RAB5A | |
Organism | Homo sapiens (Human). | |
Sequence Length | 215 | |
Subcellular Localization |
Cell membrane Lipid-anchor Cytoplasmic side . Early endosome membrane Lipid-anchor . Melanosome . Cytoplasmic vesicle . Cell projection, ruffle . Membrane . Cytoplasm, cytosol. Cytoplasmic vesicle, phagosome membrane . Endosome membrane . Enric |
|
Protein Description | The small GTPases Rab are key regulators of intracellular membrane trafficking, from the formation of transport vesicles to their fusion with membranes. Rabs cycle between an inactive GDP-bound form and an active GTP-bound form that is able to recruit to membranes different sets of downstream effectors directly responsible for vesicle formation, movement, tethering and fusion. RAB5A is required for the fusion of plasma membranes and early endosomes. [PubMed: 10818110] | |
Protein Sequence | MASRGATRPNGPNTGNKICQFKLVLLGESAVGKSSLVLRFVKGQFHEFQESTIGAAFLTQTVCLDDTTVKFEIWDTAGQERYHSLAPMYYRGAQAAIVVYDITNEESFARAKNWVKELQRQASPNIVIALSGNKADLANKRAVDFQEAQSYADDNSLLFMETSAKTSMNVNEIFMAIAKKLPKNEPQNPGANSARGRGVDLTEPTQPTRNQCCSN | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MASRGATRP ------CCCCCCCCC | 14.13 | - | |
3 | Phosphorylation | -----MASRGATRPN -----CCCCCCCCCC | 29.92 | 25159151 | |
4 | Methylation | ----MASRGATRPNG ----CCCCCCCCCCC | 29.27 | 115489929 | |
7 | Phosphorylation | -MASRGATRPNGPNT -CCCCCCCCCCCCCC | 49.86 | - | |
14 | Phosphorylation | TRPNGPNTGNKICQF CCCCCCCCCCCCCEE | 45.31 | 28348404 | |
22 | Acetylation | GNKICQFKLVLLGES CCCCCEEEEEEECCC | 16.29 | 25953088 | |
29 | Phosphorylation | KLVLLGESAVGKSSL EEEEECCCCCCCCHH | 26.84 | 23911959 | |
33 | Ubiquitination | LGESAVGKSSLVLRF ECCCCCCCCHHHHHH | 30.21 | - | |
33 | Ubiquitination | LGESAVGKSSLVLRF ECCCCCCCCHHHHHH | 30.21 | - | |
35 | Phosphorylation | ESAVGKSSLVLRFVK CCCCCCCHHHHHHHC | 26.44 | 20860994 | |
51 | Phosphorylation | QFHEFQESTIGAAFL CCHHHHHHHHCHHEE | 17.97 | 26126808 | |
52 | Phosphorylation | FHEFQESTIGAAFLT CHHHHHHHHCHHEEE | 23.76 | 26126808 | |
59 | Phosphorylation | TIGAAFLTQTVCLDD HHCHHEEEEEEECCC | 18.75 | 26126808 | |
61 | Phosphorylation | GAAFLTQTVCLDDTT CHHEEEEEEECCCCE | 14.14 | 26126808 | |
82 | Phosphorylation | DTAGQERYHSLAPMY CCCCCCCCHHHCCCH | 8.60 | 25106551 | |
84 | Phosphorylation | AGQERYHSLAPMYYR CCCCCCHHHCCCHHC | 19.79 | 28857561 | |
88 | Sulfoxidation | RYHSLAPMYYRGAQA CCHHHCCCHHCCCCE | 3.69 | 28183972 | |
102 | Ubiquitination | AAIVVYDITNEESFA EEEEEEECCCHHHHH | 2.14 | 21890473 | |
116 | Acetylation | ARAKNWVKELQRQAS HHHHHHHHHHHHHCC | 44.30 | 26051181 | |
116 | Ubiquitination | ARAKNWVKELQRQAS HHHHHHHHHHHHHCC | 44.30 | 21890473 | |
116 | Ubiquitination | ARAKNWVKELQRQAS HHHHHHHHHHHHHCC | 44.30 | 2189047 | |
120 | Ubiquitination | NWVKELQRQASPNIV HHHHHHHHHCCCCEE | 46.81 | - | |
123 | Phosphorylation | KELQRQASPNIVIAL HHHHHHCCCCEEEEE | 15.33 | 25159151 | |
134 | Ubiquitination | VIALSGNKADLANKR EEEECCCHHHHCCCC | 46.96 | - | |
140 | Ubiquitination | NKADLANKRAVDFQE CHHHHCCCCCCCHHH | 35.81 | - | |
160 | Sulfoxidation | DDNSLLFMETSAKTS CCCCEEEEECCCCCC | 5.76 | 30846556 | |
165 | Ubiquitination | LFMETSAKTSMNVNE EEEECCCCCCCCHHH | 40.68 | - | |
193 | Phosphorylation | PQNPGANSARGRGVD CCCCCCCCCCCCCCC | 20.86 | 29255136 | |
197 | Methylation | GANSARGRGVDLTEP CCCCCCCCCCCCCCC | 36.09 | 115489935 | |
202 | Phosphorylation | RGRGVDLTEPTQPTR CCCCCCCCCCCCCCC | 35.14 | 18669648 | |
205 | Phosphorylation | GVDLTEPTQPTRNQC CCCCCCCCCCCCCCC | 40.73 | 18669648 | |
208 | Phosphorylation | LTEPTQPTRNQCCSN CCCCCCCCCCCCCCC | 32.22 | 18669648 | |
212 | Geranylgeranylation | TQPTRNQCCSN---- CCCCCCCCCCC---- | 2.91 | 7991565 | |
212 | Geranylgeranylation | TQPTRNQCCSN---- CCCCCCCCCCC---- | 2.91 | 7991565 | |
213 | Geranylgeranylation | QPTRNQCCSN----- CCCCCCCCCC----- | 2.92 | 7991565 | |
213 | Geranylgeranylation | QPTRNQCCSN----- CCCCCCCCCC----- | 2.92 | 7991565 |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
84 | S | Phosphorylation |
| 29125462 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RAB5A_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-202; THR-205 ANDTHR-208, AND MASS SPECTROMETRY. | |
Prenylation | |
Reference | PubMed |
"Rab geranylgeranyl transferase catalyzes the geranylgeranylation ofadjacent cysteines in the small GTPases Rab1A, Rab3A, and Rab5A."; Farnsworth C.C., Seabra M.C., Ericsson L.H., Gelb M.H., Glomset J.A.; Proc. Natl. Acad. Sci. U.S.A. 91:11963-11967(1994). Cited for: NUCLEOTIDE SEQUENCE [MRNA], ISOPRENYLATION AT CYS-212 AND CYS-213, ANDMASS SPECTROMETRY. |